Toggle Nav Phone Number Call My Quote My Cart Deals Industries Resources Request a Quote US CAN - en Investor Relations Annual Reports | Corporate Governance | Earnings Releases | Investor Contacts | SEC Filings | Investor Presentation | Acquisitions Transcat (Nasdaq:TRNS) has been a leader in the test and measurement industry for over 40 years. We strive to differentiate ourselves and build barriers to competitive entry by offering the best products, delivering high quality calibration and repair services, and integrating those products and services. We work diligently to create lasting value for our shareholders. Strategy Our strategy is to continue to grow our business through a blend of organic revenue growth and acquisitions. We leverage the complementary nature of our operating segments in ways that add value for all customers who select Transcat as their source for test and measurement equipment and/or calibration and laboratory instrument services. We believe our combined Service and Distribution segment offerings, experience, technical expertise and quality-oriented, integrity-based approach create a unique and compelling value proposition for our customers. We strive to differentiate ourselves within the markets we serve and build barriers to competitive entry by offering a broad range of the best products and services, and integrating those products and services to benefit our customers’ operations. Annual Reports Get access to Transcat’s annual reports, read meeting transcripts and view annual report presentations Earnings Releases View Transcat’s earnings releases, listen to presentation webcasts or view the presentation slides Corporate Governance View Transcat's corporate governance guidelines, board of directors, executive officers and senior management Recent Company News Transcat Reports Second Quarter Adjusted EBITDA Increase of 35.5% to $7.1 Million on Strong Revenue Growth and Gross Margin Expansion ROCHESTER, NY, November 2, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its second quarter ended September 25, 2021 (the “second quarter”) of fiscal year 2022, which ends March 26, 2022 (“fiscal 2022”). Results include the previously reported acquisitions of BioTek Services, Inc. (“BioTek”) effective December 16, 2020, Upstate Metrology (“Upstate”) effective April 29, 2021 and Cal OpEx Limited (d/b/a NEXA Enterprise Asset Management), (“NEXA”) effective August 31, 2021. Press Release Listen to the Webcast View the Presentation Transcat Announces Second Quarter Fiscal Year 2022 Conference Call and Webcast ROCHESTER, NY, October 18, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year 2022 results after the close of financial markets on Tuesday, November 2, 2021. Press Release Listen to the Webcast Transcat Expands Life Science Service Capabilities and Geographic Reach into Ireland with Acquisition of NEXA Enterprise Asset Management ROCHESTER, NY, August 31, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held Cal Opex Limited (d/b/a NEXA Enterprise Asset Management), effective August 31, 2021. The purchase price of $22.5 million consisted of $20.25 million in cash and $2.25 million in Transcat common stock. Additionally, there are potential earn-out payments of up to $7.5 million over the next four years based upon NEXA achieving certain annual revenue and EBITDA goals. If achieved, the earn-out payments will also be made in common stock. Press Release Join the Webinar View the Presentation For further information, please contact: Mark A. Doheny CFO 35 Vantage Point Drive Rochester, NY 14624 Phone: 585.484.1350 Email: mark.doheny@transcat.com Contact Us Transcat makes it easy: to buy instruments with calibration from a SINGLE SOURCE! ALSO OF INTEREST Transcat Quote Request & Contact Form Quality Program Industries SUBSCRIBE TO OUR NEWSLETTER TRANSCAT, INC 35 Vantage Point Drive Rochester, NY 14624 CUSTOMER SERVICE 800-633-0561 Contact Transcat Open: Mon-Fri 8am to 7pm EST Covid 19 Response C3 Login Catalog Request Return Policy Sales and Customer Service Investor Relations News Releases About Us Contact Us Lab Locations FAQs Careers Terms & Conditions Go to Transcat Canada ©2018 Transcat, Inc. All Rights Reserved Terms and Conditions Privacy Policy